PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $22,394,000 | -60.2% | 488,418 | -48.6% | 0.02% | -61.8% |
| Q2 2018 | $56,252,000 | +70.2% | 950,998 | +95.9% | 0.06% | +66.7% |
| Q1 2018 | $33,041,000 | +133.3% | 485,545 | +126.3% | 0.03% | +153.8% |
| Q2 2014 | $14,160,000 | -68.3% | 214,547 | -50.1% | 0.01% | -69.8% |
| Q1 2014 | $44,739,000 | +5.5% | 429,608 | +4.9% | 0.04% | +2.4% |
| Q4 2013 | $42,413,000 | +8.1% | 409,665 | -44.0% | 0.04% | +2.4% |
| Q3 2013 | $39,253,000 | -3.3% | 731,511 | -20.1% | 0.04% | -10.9% |
| Q2 2013 | $40,603,000 | – | 915,096 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $13,338,000 | 2.17% |
| Camber Capital Management LP | 2,555,000 | $26,214,000 | 0.92% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,959,741 | $40,627,000 | 0.80% |
| Palo Alto Investors LP | 1,373,897 | $14,096,000 | 0.74% |
| Sofinnova Investments, Inc. | 629,650 | $6,460,000 | 0.38% |
| RICE HALL JAMES & ASSOCIATES, LLC | 604,937 | $6,207,000 | 0.22% |
| J. Goldman & Co LP | 238,617 | $2,448,000 | 0.12% |
| GLOBEFLEX CAPITAL L P | 55,027 | $565,000 | 0.12% |
| FRED ALGER MANAGEMENT, LLC | 3,416,003 | $35,048,000 | 0.09% |
| JUPITER ASSET MANAGEMENT LTD | 728,440 | $7,474,000 | 0.08% |